YVONNE KEW
Dr. Yvonne Kew is a neuro-oncology specialist in Houston, Texas and has been practicing for over 20 years. She graduated from Albert Einstein College of Medicine with both her M.D. and Ph.D. in 1998. She completed her residency at Baylor College of Medicine in 2002 and fellowship at UT M.D. Anderson Cancer Center in 2004. Dr. Kew is affiliated with CHI St. Luke’s Health Baylor St. Luke’s Medical Center.
Confira a agenda de atividades
22 DE MARÇO | SEXTA-FEIRA
• Room 2
08:15-10:30
SESSION 1: MENINGIOMAS AND EPENDYMOMAS
Can MRI predict meningioma behavior and grade?
Evidence-based treatment of cavernous sinus meningioma: microsurgery Vs radiotherapy
Radiation therapy for skull base meningiomas
Optimizing surgical approaches for anterior fossa meningiomas: a comprehensive evaluation
New trends in ependymoma pathology
What is the best radiation therapy approach for ependymoma?
Systemic treatment of recurrent ependymomas
Discussion
Moderator: Larissa Nubia Nunes Vilany (SP)
Moderator: Marcelo Lemos Vieira da Cunha (SC)
Moderator: Thiago William Carnier Jorge (SP)
Can MRI predict meningioma behavior and grade?
Speaker: Nelson Fortes (SP)
Evidence-based treatment of cavernous sinus meningioma: microsurgery Vs radiotherapy
Speaker: Cleiton Formentin (SP)
Radiation therapy for skull base meningiomas
Speaker: Lais Maya (SP)
Optimizing surgical approaches for anterior fossa meningiomas: a comprehensive evaluation
Speaker: Antonio Aversa Dutra Do Souto (RJ)
New trends in ependymoma pathology
Speaker: Felipe D’almeida Costa (SP)
What is the best radiation therapy approach for ependymoma?
Speaker: Douglas Guedes de Castro (SP)
Systemic treatment of recurrent ependymomas
Speaker: Yvonne Kew (Estados Unidos)
Discussion
23 DE MARÇO | SÁBADO
• Room 1
08:15-10:30
SESSION 3: DIFFUSE GLIOMAS
Cannabinoids in glioma treatment
How should be clinical and cognitive assessment in neurooncology?
Advances in patients specific brain mapping strategies
Is there any role for radiosurgery in recurrent gliomas?
The role of re-resection for recurrent IDHwt gliomas
Neuroplasticity and neuroprotection under the radiation oncologist view
Is dexamethasone still the best friend of neuro oncologist?
Discussion
Moderator: Joab Alves Nicacio Junior (SP)
Moderator: Lucas Alverne Freitas de Albuquerque (CE)
Moderator: Gustavo Matos (DF)
Cannabinoids in glioma treatment
Speaker: Juan Sepulveda (Espanha)
How should be clinical and cognitive assessment in neurooncology?
Speaker: Yvonne Kew (Estados Unidos)
Advances in patients specific brain mapping strategies
Speaker: Shawn Hervey-jumper (Estados Unidos)
Is there any role for radiosurgery in recurrent gliomas?
Speaker: Marcos Duarte de Mattos (SP)
The role of re-resection for recurrent IDHwt gliomas
Speaker: Sujit Prabhu (Estados Unidos)
Neuroplasticity and neuroprotection under the radiation oncologist view
Speaker: Fabio Ynoe de Moraes (Canadá)
Is dexamethasone still the best friend of neuro oncologist?
Speaker: Adrialdo José Santos (SP)
Discussion
13:30-15:30
SESSION 4: DIFFUSE GLIOMAS
A Critical Overview of Targeted Therapies for Glioma
Translational research for gliomas: future landscapes and emerging paradigm
The role of CAR T cell therapy in neurooncology
What we do know about non-standard of care treatments for gliomas: cannabis, antidepressants, metformin and others
Bevacizumab, is there still a role for antiangiogenics in glioblastoma?
The optimal timing of palliative care in glioma patients
How feasible is surgery in the motor area?
Discussion
Moderator: ícaro Thiago de Carvalho (SP)
A Critical Overview of Targeted Therapies for Glioma
Speaker: Tracy Batchelor (Estados Unidos)
Translational research for gliomas: future landscapes and emerging paradigm
Speaker: Vinay K. Puduvalli (Estados Unidos)
The role of CAR T cell therapy in neurooncology
Speaker: Andreas Hottinger (Suíça)
What we do know about non-standard of care treatments for gliomas: cannabis, antidepressants, metformin and others
Speaker: Yvonne Kew (Estados Unidos)
Bevacizumab, is there still a role for antiangiogenics in glioblastoma?
Speaker: Juan Sepulveda (Espanha)
The optimal timing of palliative care in glioma patients
Speaker: Daniel Neves Forte (SP)
How feasible is surgery in the motor area?
Speaker: Lorenzo Bello (Itália)
Discussion
Realização
Organização
agência de turismo
PATROCÍNIO PRATA
PATROCÍNIO BRONZE
APOIO
Apoio Institucional
